About Rapid Micro Biosystems
Rapid Micro Biosystems is a company based in Bedford (United Kingdom) founded in 2006. Rapid Micro Biosystems has raised $349.7 million across 15 funding rounds from investors including Kleiner Perkins, Comerica and BlackRock. The company has 163 employees. Rapid Micro Biosystems offers products and services including Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables. Rapid Micro Biosystems operates in a competitive market with competitors including BacterOMIC and Rapiddx Technologies, among others.
- Headquarter Bedford, United Kingdom
- Employees 163
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website rapidmicrobio.com
- Social LinkedIn X YouTube
- Legal Name Rapid Micro Biosystems, Inc.
- Annual Revenue$33.59 M (USD)19.74as on Dec 31, 2025
- Net Profit-$47.12 M (USD)-0.5as on Dec 31, 2025
- EBITDA-$44.14 M (USD)5.19as on Dec 31, 2025
- Total Equity Funding$349.7M (USD)
in 15 rounds
- Latest Funding Round$81M (USD), Series E
Mar 2021
- InvestorsKleiner Perkins
& 21 more
- Employee Count163
Products & Services of Rapid Micro Biosystems
Rapid Micro Biosystems offers a comprehensive portfolio of products and services, including Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables.
Automated platform for rapid microbial quality control testing
Technology for quick detection of contaminants in samples
Software for managing and analyzing microbial test data
Items used in automated microbial testing processes
Apps and channels of Rapid Micro Biosystems
its YouTube channel Rapid Micro Biosystems has 123 subscribers and 7 videos.
Videos from Rapid Micro Biosystems
The most watched videos on Rapid Micro Biosystems's YouTube channel, Rapid Micro Biosystems (123 subscribers). Click a video to play it here.
More on Rapid Micro Biosystems.
Funding Insights of Rapid Micro Biosystems
Rapid Micro Biosystems has successfully raised a total of $349.7M across 15 strategic funding rounds. The most recent funding activity was a Series E round of $81 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $349.7M
- Total Rounds 15
- Last Round Series E — $81M
- First Round $2.59M
(Jun 2006)
- Investors Count 22
Latest 10 of 15 funding rounds of Rapid Micro Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $81M | Series E | – | BlackRock, Xeraya Capital | – |
| May 2020 | – | Debt – Conventional | – | – | |
| May 2020 | $120M | Series E | – | Endeavour Vision, Ally Bridge Group | |
| May 2018 | $60.02M | Series D | – | Xeraya Capital, Bain Capital Life Sciences | |
| Aug 2015 | – | Series C | – | – | |
| Jul 2015 | $19M | Debt – Venture | – | – | |
| May 2015 | $25M | Series C | – | – | |
| Mar 2015 | $6M | Debt – Venture | – | – | – |
| Apr 2014 | $6M | Series B | – | – | |
| Jun 2013 | $32.6M | Series B | – | Longitude Capital, TPG |
22 investors in total: 22 institutional.
Investors in Rapid Micro Biosystems
Rapid Micro Biosystems has secured backing from 22 investors, including institutional and venture fund investors. Prominent investors backing the company include Kleiner Perkins, Comerica and BlackRock.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | – | xeraya.com | Kuala Lumpur, Malaysia | |
Private equity and hedge fund investments in healthcare are managed. | – | ally-bridge.com | Hong Kong, China | |
Endeavour Vision is focused on transformative healthcare technology investments. | – | endeavourvision.com | Geneva, Switzerland | |
Growth investments are managed by this private equity firm. | – | sunleyhouse.com | Boston, United States | |
Investments are focused on pharmaceutical, biotechnology, and medical sectors. | – | baincapitallifesciences.com | Boston, United States | |
Innovative global companies are supported through venture capital investments by Asahi Kasei Ventures. | 1922 | asahikaseiventures.com | Tokyo, Japan | |
Private equity firm focused on life science sector | – | longitudecapital.com | Menlo Park, United States | |
Capital is invested in life science innovations for healthcare transformation. | – | tvm-capital.com | Munich, Germany | |
Government-backed investments are directed toward healthcare, fintech, and various sectors. | – | edbi.com | Singapore, Singapore | |
Debt and equity investments are offered by the firm. | 2006 | solarcapltd.com | New York, United States |
Investor details for Rapid Micro Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rapid Micro Biosystems
57 people are tracked at Rapid Micro Biosystems (14 in leadership, 43 in team); the tracked headcount is 163.
| Name | Role | Group |
|---|---|---|
Michael Wilt | Director of Sustaining Engineering | Leadership |
Brian Conti | Senior Director, Sterility | Leadership |
Carolyn Dowling | Director, Customer Experience | Leadership |
Julie Jarvie | Svp, Head Of HR | Leadership |
Shelby Williams | Sr. Director Of Financial Planning & Analysis | Leadership |
Jim Lafferty | Vice President, Operations And Quality | Leadership |
Sean Wirtjes | CFO | Leadership |
John Wilson | COO | Leadership |
Robert Spignesi | President & CEO | Leadership |
Owen Griffin | Senior Director, Microbiology | Leadership |
Todd Ballantyne | Vice President Of Research And Development | Leadership |
Katrina Weiss | Vice President Operations | Leadership |
Serge Ohresser | Director Of Customer Success | Leadership |
Bruce Ryan | Sr. Director, Global Marketing | Leadership |
Zoilo Rosario | Engineer Ii, Sustaining | Team |
Szilard Attila Krija | Field Services Engineer | Team |
Li-Ching Jong | Business Development Manager | Team |
Josh Price | Principal Process Engineer | Team |
Masaomi Karakawa | Senior Field Service Engineer | Team |
Jonathan Pichardo | Field Service Engineer | Team |
37 more people are available in the full profile.
Complete people profiles for Rapid Micro Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Rapid Micro Biosystems
Rapid Micro Biosystems is a publicly listed company on the NASDAQ with ticker symbol RPID in USA, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jul 2021
- Listed onNASDAQ: RPID
- Listed entityRapid Micro Biosystems, Inc.
- Exchange sectorProducer manufacturing
- ISINUS75340L1044
- Share price$0.89 (+3.69% on the day) · 2026-10-09
- Market capitalisation$44.8M
- EPS (diluted, trailing year)$-1.12
- Volume (last session)214,527
Financials of Rapid Micro Biosystems
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $33.6M | -$47.1M | -$44.1M |
| 2024 | $28.1M | -$46.9M | -$46.6M |
| 2023 | $22.5M | -$52.5M | -$53.5M |
| 2022 | $17.1M | -$60.8M | -$59.2M |
| 2021 | $23.2M | -$73.5M | -$45.6M |
Detailed financial statements for Rapid Micro Biosystems
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Rapid Micro Biosystems
4 dated milestones of Rapid Micro Biosystems across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Rapid Micro Biosystems is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Series E, of $81.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Rapid Micro Biosystems
Rapid Micro Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BacterOMIC and Rapiddx Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bacteromic.com | 2017 | Warsaw, Poland | – | – | Developer of a system for antibiotic susceptibility testing | |
| rapiddxtech.com | 2019 | Bengaluru, India | – | – | Antimicrobial susceptibility platform is developed via microfluidics and sensor technology. |
Detailed competitors of Rapid Micro Biosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rapid Micro Biosystems
The website of Rapid Micro Biosystems (rapidmicrobio.com) receives about 6.2K visits a month and ranks #3,316,486 among all websites worldwide, #4,361 in Biotechnology and Pharmaceuticals.
- Monthly visits6.2K
▲ 9.5% vs previous month
- Unique visitors2.4K
per month
- Global rank#3,316,486
among all websites
- Category rank#4,361
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.9
- Average visit9 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Rapid Micro Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chiesiusa.com | chiesiusa.com | 100% | – | #1,397,563 | – |
a3p.org | a3p.org | 100% | – | #1,414,393 | – |
| fffenterprises.com | 94% | – | #604,554 | View details | |
ucb-usa.com | ucb-usa.com | 94% | – | #1,210,289 | – |
 pharmaceuticalvalidation.blogspot.com | pharmaceuticalvalidation.blogspot.com | 84% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 32 similar websites and full traffic analytics for Rapid Micro Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 32 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Rapid Micro Biosystems
Complete news archive for Rapid Micro Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Rapid Micro Biosystems
10 companies that operate in the same segment as Rapid Micro Biosystems (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rapid Micro Biosystems
Rapid Micro Biosystems was founded in 2006.
Rapid Micro Biosystems is headquartered in Bedford, United Kingdom. It is registered at Bedford, Bedfordshire, United Kingdom.
Rapid Micro Biosystems is a funded company, having raised a total of $349.7M across 15 funding rounds to date. The company's 1st funding round was a Series B of $32.6M, raised on Jun 2006.
Rapid Micro Biosystems has 163 employees.
Annual revenue of Rapid Micro Biosystems is $33.59M as on Dec 31, 2025.
Founded in 2006, Rapid Micro Biosystems operates in the biotechnology sector, focusing on microbial detection solutions. The Growth Direct system is provided, featuring automated imaging for early microcolony counting via autofluorescence measurement. Services such as on-site installation, instrument validation, and regulatory compliance support are offered. Applications include environmental monitoring, sterility testing, and bioburden analysis, with operations based in Bedford, United Kingdom.
Rapid Micro Biosystems's top competitors include BacterOMIC and Rapiddx Technologies.
Rapid Micro Biosystems offers Growth Direct System, Rapid Detection, RMBNucleus Software, and Consumables.
Yes, Rapid Micro Biosystems is publicly traded on NASDAQ under the ticker symbol RPID.
Rapid Micro Biosystems has 22 investors. Key investors include Kleiner Perkins, Comerica, BlackRock, TPG, and T. Rowe Price.
Rapid Micro Biosystems operates through Rapid Micro Biosystems, Inc..